We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| UnitedHealth Group Inc | NYSE:UNH | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -7.40 | -1.41% | 517.23 | 524.65 | 516.54 | 524.63 | 2,472,759 | 01:00:00 |
From May 2021 to May 2024
By Chris Wack
UnitedHealth Group Inc.'s deal to buy LHC Group Inc. for about $5.4 billion in cash got the thumbs up from analysts at Mizuho Securities USA, saying the merger would bolster UnitedHealth's OptumCare business.
UnitedHealth shares hit their 52-week high of $519.59 on Tuesday, and were trading just about flat at $509.01 at 12:20 p.m. ET. LHC Group shares were trading up 6% to $166.48.
Mizuho said in a note that the LHC Group deal is a "nice bolt-on strategic fit" for OptumCare, a part of the OptumHealth business, and is intended to enhance the company's home-healthcare capability.
The analysts expect the deal to be accretive to 2023 earnings by about 1%, while UnitedHealth said the deal would be neutral in 2022, and moderately accretive in 2023.
Mizuho estimates that LHC Group will contribute 3% to 4% of total OptumHealth revenue after the combination and about 5% of total OptumHealth operating profit.
Mizuho said the combination with LHC Group is expected to enhance OptumCare's home-based care and hospice capabilities, and strengthen UnitedHealth's value-based care model.
The analyst reiterated its Buy rating of UnitedHealth, with a price target of $550 a share.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
March 29, 2022 13:00 ET (17:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year UnitedHealth Chart |
1 Month UnitedHealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
